Therapeutic agent for schizophrenia

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/048 (2006.01) A61K 31/4741 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01) A61P 43/00 (2006.01) C07D 491/04 (2006.01)

Patent

CA 2512765

A drug that is useful for treating schizophrenia. In particular, a therapeutic agent for schizophrenia comprising as an active ingredient a 4-acylamino- 5,6,7,8-tetrahydrofuro[2,3-b]quinoline derivative, or its optical enantiomorph or acid adduct salt, or a hydrate or solvate thereof.

L'invention concerne un médicament utile pour le traitement de la schizophrénie, et en particulier un agent pour ce traitement qui comprend comme principe actif un dérivé de 4-acylamino-5,6,7,8-tétrahydrofuro[2,3-b]quinoline, ou son énantiomorphe optique ou sel d'addition d'acide, ou bien un hydrate ou un solvate correspondant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic agent for schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for schizophrenia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1741768

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.